Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2004

View Archived Issues

Nabi remains on track to achieve key 2004 milestones

Antitumor efficacy of ABX-EGF in metastatic renal cancer

Preoperative gabapentin reduces the need for analgesics following vaginal hysterectomy

ChemDiv and Yale University receive STTR grant

ViroPharma sells biodefense assets for antiviral drug to SIGA Technologies

Thiophene-based PPARdelta agonist with high potency and selectivity

Safe and effective new antiasthmatic agent, OS-0217, characterized at ACS meeting

Results from Thelin and Viagra drug-drug interaction study

Biovail, Schering-Plough terminate Cedax agreement, Shionogi takes rights

Orphan drug designation for AGRO-100

Sankyo and Fujisawa terminate agreements for CS-758

Novel DPP-IV inhibitors developed at Merck & Co.

Merck scientists identify new cannabinoid CB1 modulators for obesity and other uses

New modulators of chemokine CCXCKR2 receptors and their use in cancer therapy

New factor Xa inhibitors in early development at Lilly

Modulators of PDE4, MMP and/or TNF-alpha discovered at Celgene

Novel tryptase inhibitor covered by Aventis patent

Amgen claims CDK inhibitors and their use

PEP-005 initiates human clinical trials

Biovitrum acquires oncology project from Karolinska

Ark signs marketing agreement with Teva for Keraboot in Israel

Johnson & Johnson to acquire Biapharm

SPA agreement for pivotal studies of Corlux

Approvable letter for Certican

New integrin receptor antagonists presented at the recent ACS meeting

New-generation antibiotics show efficacy against burn wound infections

Favorable properties described for Neuropharma's novel thiazolidinediones

Positive new phase II results for Liprostin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...